New Delhi, April 17 -- The inverted duty structure resulting from rate changes under the Goods and Services Tax (GST) 2.0 regime is hurting companies especially in the FMCG and over-the-counter (OTC) pharma sectors, with high input-side taxation on key services leading to accumulation of credits, Khaitan & Co Indirect Tax Partner, Sudipta Bhattacharjee told ANI on Friday.

"The whole issue of inverted duty structure emerging after GST 2.0 has started hurting a lot of companies in the FMCG or over-the-counter drugs business," Bhattacharjee said.

Citing the reason for the same, he said this is mainly "because for them there is a massive expense on the input side for services like which marketing and advertising services on which there is 1...